Mon, 20 May 2013 19:52Other additions to Ignyta's management team include Jean-Michel Vernier, Ph.D., who formerly led chemistry groups at Ardea Biosciences, Valeant Pharmaceuticals and Merck Research Laboratories, to serve as VP, Medicinal Chemistry; Paul Pearson, Ph.D.

Thu, 02 May 2013 12:01Dr. Quart was most recently President and Chief Executive Officer of Ardea Biosciences, Inc., a biopharmaceutical company, since its founding in December 2006. Ardea was acquired by AstraZeneca PLC for $1.26 billion in June 2012. Previously, he was ...

Thu, 25 Apr 2013 12:52Morrison, who joined AstraZeneca about a year ago, says he's wide open to doing another deal like Ardea Biosciences ($RDEA), which the pharma giant acquired for $1.26 billion. That deal delivered a late-stage drug for gout which quickly emerged as one ...